Cassava Sciences Valuation
| SAVA Stock | USD 2.09 0.04 1.95% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Cassava Sciences shows a prevailing Real Value of $3.52 per share. The current price of the firm is $2.09. Our model approximates the value of Cassava Sciences from analyzing the firm fundamentals such as Return On Equity of -0.89, shares owned by insiders of 12.78 %, and Current Valuation of (19.21 M) as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Cassava Sciences' valuation include:
Undervalued
Today
Please note that Cassava Sciences' price fluctuation is very risky at this time. Calculation of the real value of Cassava Sciences is based on 3 months time horizon. Increasing Cassava Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cassava Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cassava Stock. However, Cassava Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.09 | Real 3.52 | Target 8.0 | Hype 2.05 |
The real value of Cassava Stock, also known as its intrinsic value, is the underlying worth of Cassava Sciences Company, which is reflected in its stock price. It is based on Cassava Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cassava Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cassava Sciences helps investors to forecast how Cassava stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cassava Sciences more accurately as focusing exclusively on Cassava Sciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Cassava Sciences' intrinsic value based on its ongoing forecasts of Cassava Sciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Cassava Sciences' closest peers. If more than one evaluation category is relevant for Cassava Sciences we suggest using both methods to arrive at a better estimate.
Cassava Sciences Cash |
|
Cassava Sciences Total Value Analysis
Cassava Sciences is at this time anticipated to have valuation of (19.21 M) with market capitalization of 142.03 M, debt of 11.83 M, and cash on hands of 197.23 M. The negative valuation of Cassava Sciences may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Cassava Sciences fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(19.21 M) | 142.03 M | 11.83 M | 197.23 M |
Cassava Sciences Asset Utilization
One of the ways to look at asset utilization of Cassava is to check how much profit was generated for every dollar of assets it reports. Cassava Sciences shows a negative utilization of assets of -0.3 percent, losing $0.002968 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cassava Sciences shows how discouraging it operates for each dollar spent on its assets.Cassava Sciences Profitability Analysis
Based on Cassava Sciences' profitability indicators, Cassava Sciences' profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Cassava Sciences' ability to earn profits and add value for shareholders.Net Loss | First Reported 2000-03-31 | Previous Quarter -44.2 M | Current Value -10.8 M | Quarterly Volatility 9.8 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.8 | 0.9 |
|
|
For Cassava Sciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cassava Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cassava Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cassava Sciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cassava Sciences over time as well as its relative position and ranking within its peers.
Cassava Sciences Earnings per Share Projection vs Actual
The next projected EPS of Cassava Sciences is estimated to be -0.305 with future projections ranging from a low of -0.305 to a high of -0.305. Cassava Sciences' most recent 12-month trailing earnings per share (EPS TTM) is at -2.22. Please be aware that the consensus of earnings estimates for Cassava Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Cassava Sciences Earnings Estimation Breakdown
The calculation of Cassava Sciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Cassava Sciences is estimated to be -0.305 with the future projection ranging from a low of -0.305 to a high of -0.305. Please be aware that this consensus of annual earnings estimates for Cassava Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.3 Lowest | Expected EPS | -0.3 Highest |
Cassava Sciences Earnings Projection Consensus
Suppose the current estimates of Cassava Sciences' value are higher than the current market price of the Cassava Sciences stock. In this case, investors may conclude that Cassava Sciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Cassava Sciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 1 | 64.06% | 0.0 | -0.305 | -2.22 |
Cassava Sciences Ownership Allocation
Cassava Sciences holds a total of 48.31 Million outstanding shares. Cassava Sciences shows 12.78 percent of its outstanding shares held by insiders and 24.63 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cassava Sciences Profitability Analysis
Net Loss for the year was (24.34 M) with loss before overhead, payroll, taxes, and interest of (56.99 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cassava Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cassava Sciences and how it compares across the competition.
About Cassava Sciences Valuation
The stock valuation mechanism determines Cassava Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cassava Sciences. We calculate exposure to Cassava Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cassava Sciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1 M | -967.9 K | |
| Pretax Profit Margin | 0.69 | 0.72 | |
| Operating Profit Margin | 0.88 | 0.83 | |
| Net Profit Margin | 0.69 | 0.72 | |
| Gross Profit Margin | 0.90 | 0.80 |
Cassava Sciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 46.6 M | |
| Forward Price Earnings | 151.5152 |
Cassava Sciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Cassava Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cassava we look at many different elements of the entity such as Cassava's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cassava Sciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cassava Sciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cassava Sciences' worth.Complementary Tools for Cassava Stock analysis
When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |